|
|
|
MIRA INFORM REPORT
|
Report No. : |
494854 |
|
Report Date : |
05.03.2018 |
IDENTIFICATION DETAILS
|
Name : |
LABORATORIOS VIJOSA S.A DE C.V |
|
|
|
|
Registered Office : |
Calle L-3, No. 10, Zona Industrial Merliot, Antiguo
Cuscatlán, El Salvador, Central America |
|
|
|
|
Country : |
El Salvador |
|
|
|
|
Financials (as on) : |
2016 [Summarized] |
|
|
|
|
Date of Incorporation : |
1971 |
|
|
|
|
Legal Form : |
Sociedad Anónima De Capital Variable |
|
|
|
|
Line of Business : |
Subject is a laboratory dedicated to the elaboration and
commercialization of medicines in its different pharmaceutical forms:
injectables, tablets, capsules, liquid packs, syrups and eye drops. |
|
|
|
|
No. of Employees : |
752 |
RATING & COMMENTS
(Mira Inform has adopted New Rating mechanism w.e.f. 23rd
January 2017)
|
MIRA’s Rating : |
A+ |
|
Credit Rating |
Explanation |
Rating Comments |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List
|
Country Name |
Previous Rating (30.09.2017) |
Current Rating (31.12.2017) |
|
El Salvador |
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low Risk |
A2 |
|
Moderately Low Risk |
B1 |
|
Moderate Risk |
B2 |
|
Moderately High Risk |
C1 |
|
High Risk |
C2 |
|
Very High Risk |
D |
EL SALVADOR - ECONOMIC OVERVIEW
The smallest country in Central America geographically, El Salvador has the
fourth largest economy in the region. With the global recession, real GDP
contracted in 2009 and economic growth has since remained low, averaging less
than 2% from 2010 to 2014, but recovered somewhat in 2015-17 with an average
annual growth rate of 2.4%. Remittances accounted for approximately 17.1% of
GDP in 2016 and were received by about a third of all households.
In 2006, El Salvador was the first country to ratify the Dominican
Republic-Central American Free Trade Agreement, which has bolstered the export
of processed foods, sugar, and ethanol, and supported investment in the apparel
sector amid increased Asian competition. In September 2015, El Salvador kicked
off a five-year $277 million second compact with the Millennium Challenge
Corporation - a US Government agency aimed at stimulating economic growth and
reducing poverty - to improve El Salvador's competitiveness and productivity in
international markets.
The Salvadoran Government maintained fiscal discipline during post-war
reconstruction and rebuilding following earthquakes in 2001 and hurricanes in
1998 and 2005, but El Salvador's public debt, estimated at 68.1% of GDP in
2017, has been growing over the last several years. Total external debt was
about 60% of GDP in 2017.
|
Source
: CIA |
STATUTORY
INFORMATION
|
|
|
Legal Name: |
LABORATORIOS VIJOSA S.A DE C.V |
|
Trade Names: |
LABORATORIOS VIJOSA S.A DE C.V |
|
ID: |
0614-240775-001-0 (NIT) 32757-3 (NRC) |
|
Date Created: |
1971 |
|
Date Incorporated: |
1971 |
|
Legal Address: |
Calle L-3, No. 10, Zona Industrial Merliot,
Antiguo Cuscatlán, El Salvador, Central America. |
|
Operative Address: |
Calle L-3, No. 10, Zona Industrial Merliot,
Antiguo Cuscatlán, El Salvador, Central America. |
|
Telephone: |
503 22519797 |
|
Fax: |
503 22783121 |
|
Legal Form: |
Sociedad Anónima De Capital Variable |
|
Email: |
info@vijosa.com |
|
Registered in: |
EL SALVADOR |
|
Website: |
www.vijosa.com |
|
Contact: |
Victor Jorge Saca Tueme– President |
|
Staff: |
752 |
|
Activity: |
NAICS 1: Pharmaceutical Preparation Manufacturing SIC 1: Pharmaceutical Preparations |
|
|
|
|
Banks: |
The company does not disclose its banking details. |
|
|
|
|
History: |
The company was founded in 1971. |
|
|
|
|
Key Developments: |
El Salvador: $ 40 million drug plant Friday, October 2, 2015 Laboratorios Vijosa started the construction of a
drug production plant in a 9-block lot in Santa Tecla, department of La
Libertad. The plant will be situated on a 9-block lot on
the highway to Santa Tecla, and the work will be developed by the German
company Bosch, which will build the project under the turnkey contract
scheme. |
|
|
|
PRINCIPAL
ACTIVITY
|
|
|
|
Vijosa is a laboratory dedicated to the elaboration and commercialization
of medicines in its different pharmaceutical forms: injectables, tablets,
capsules, liquid packs, syrups and eye drops. |
|
Products/Services description: |
The company offers injectables, tablets, capsules, liquid packs,
syrups and eye drops. |
|
Brands: |
VIJOSA Viro-Grip Neurocampolon Rocefort Fortiplex. |
|
Sales are: |
Wholesale |
|
Clients: |
Aracely Express Corp. Dba La Botica Marcruz Llc Premier Imp. Llc Plaza Izalco Wholesale |
|
Suppliers: |
Productos Quimicos Naturales SA De Cv Forma Vitrum De Mexico Sa De Cv Esensa Sa de Cv Astroquim SA De Cv Roquette Freres Accucaps Industries Limited |
|
Operations area: |
National and International |
|
The company imports from |
MEXICO FRANCE CANADA |
|
The company exports to |
The Company exports 70% of its annual sales. UNITED STATES NICARAGUA HONDURAS GUATEMALA COSTA RICA BELIZE PANAMA |
|
The subject employs |
752 employees |
|
Payments: |
Regular |
|
|
|
LOCATION
|
|
|
Headquarters : |
Calle L-3, No. 10, Zona Industrial Merliot,
Antiguo Cuscatlán, El Salvador, Central America. |
|
Comments on Address: |
- |
|
Branches: |
Plant Panamericana Highway Santa Tecla El Salvador |
|
Related Companies: |
VIPSAL #7304 P.O. BOX 025364, MIAMl, FL. 33102-5364, USA The company also has locations in Guatemala, Honduras, Dominican
Republic, Panamá and Nicaragua. However, no address are provided in the
company`s website. |
|
|
|
GROUP
STRUCTURE AND SUBSIDIARY COMPANIES
|
|
|
Listed at the stock exchange: |
NO |
|
Capital: |
NA |
|
Shareholders: |
The company does not disclose information on shareholders. The
following information has been obtained through private sources and could not
be confirmed: The major holder of this company is: |
|
Management: |
Victor Jorge Saca Tueme– President Monica Emely Saca Nustas – Marketing Manager Licda. Olga Giron López Srta. Yeni Carla López |
|
|
|
FINANCIAL
INFORMATION
|
|
|
|
The company does not make its financial
statements public. The following information has been provided by private
sources: |
|
|
|
|
USD 2016 |
|
|
Estimated Sales |
80 000 000 |
|
Cash Flow |
Normal |
|
|
|
LEGAL
FILINGS
|
|
|
|
|
|
CASES |
No records found. |
|
|
|
|
TRADEMARKS |
VIJOSA Analgesics; Anesthetics for surgical and non-surgical use;
Anti-inflammatory and antipyretic preparations; Antibiotics;… Owned by: LABORATORIOS VIJOSA, S.A. DE C.V. Serial Number: 77746674 NEURO CAMPOLON ENERGY DIETARY SUPPLEMENTS Owned by: Laboratorios Vijosa, S.A. DE C.V. Serial Number: 78557034 NERVIDOCE Dietary and nutritional supplements; Herbal supplements; Homeopathic
supplements; Medicinal herbal extracts for medical… Owned by: LABORATORIOS VIJOSA, S.A. DE C.V. Serial Number: 77793142 GRIIN COMPLEX Dietary and nutritional supplements; Herbal supplements; Homeopathic
supplements; Medicinal herbal extracts for medical… Owned by: LABORATORIOS VIJOSA, S.A. DE C.V. Serial Number: 77703592 GRIIN Dietary and nutritional supplements; Herbal supplements; Homeopathic
supplements; Medicinal herbal extracts for medical… Owned by: LABORATORIOS VIJOSA, S.A. DE C.V. Serial Number: 77703549 FORTIPLEX Dietary and nutritional supplements; Herbal supplements; Homeopathic
supplements; Medicinal herbal extracts for medical… Owned by: LABORATORIOS VIJOSA, S.A. DE C.V. Serial Number: 77705641 |
|
|
|
|
RENEWAL HISTORY |
No records found. |
|
|
|
|
OFAC Sanctions List Search |
The company is not listed in the OFAC list. |
|
|
|
SUMMARY
|
|
|
|
Laboratorios Vijosa S.A. De C.V. is a mid-sized organization in the
pharmaceutical preparation companies industry located in San Salvador, El
Salvador. It opened its doors in 1971 and now has approximately 752 employees. The company operates nationally and internationally, mainly importing
from Mexico, France and Canada. It is ACTIVE in business with no negative
records. |
|
|
|
RISK
INFORMATION
|
|
|
DEBTS |
Controlled |
|
PAYMENTS |
Regular |
|
CASH FLOW |
Normal |
|
STATUS |
Active |
|
|
|
|
INTERVIEW |
|
|
NAME |
- |
|
POSITION |
- |
|
COMMENTS |
We called number 503 22519797 several times and received no answer. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
INR 65.22 |
|
|
1 |
INR 89.71 |
|
Euro |
1 |
INR 79.50 |
|
SVC |
1 |
INR 65.04 |
Note :
Above are approximate rates obtained from sources believed to be correct
INFORMATION DETAILS
|
Analysis Done by
: |
NIY |
|
|
|
|
Report Prepared
by : |
TPT |
RATING EXPLANATIONS
|
Credit Rating |
Explanation |
Rating Comments |
|
A++ |
Minimum Risk |
Business dealings permissible with minimum
risk of default |
|
A+ |
Low Risk |
Business dealings permissible with low
risk of default |
|
A |
Acceptable Risk |
Business dealings permissible with
moderate risk of default |
|
B |
Medium Risk |
Business dealings permissible on a regular
monitoring basis |
|
C |
Medium High Risk |
Business dealings permissible preferably
on secured basis |
|
D |
High Risk |
Business dealing not recommended or on
secured terms only |
|
NB |
New Business |
No recommendation can be done due to
business in infancy stage |
|
NT |
No Trace |
No recommendation can be done as the
business is not traceable |
NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.
This score serves as a reference to assess
SC’s credit risk and to set the amount of credit to be extended. It is
calculated from a composite of weighted scores obtained from each of the major
sections of this report. The assessed factors are as follows:
·
Financial
condition covering various ratios
·
Company
background and operations size
·
Promoters
/ Management background
·
Payment
record
·
Litigation
against the subject
·
Industry
scenario / competitor analysis
·
Supplier
/ Customer / Banker review (wherever available)
This report is issued at
your request without any risk and responsibility on the part of MIRA INFORM
PRIVATE LIMITED (MIPL) or its officials.